Cefadroxil oral disintegrant tablet, and its prepn. method

A technology of cefadroxil oral cavity and cefadroxil, which is applied in the field of cefadroxil orally disintegrating tablets and its preparation, can solve the problems of not being able to fully meet the medication needs of all patients, inconvenient taking of granules, and difficulty in swallowing medication for patients, etc. To achieve the effect of shortening the dissolution time, increasing the absorption point, and good compliance

Active Publication Date: 2007-04-25
CSPC ZHONGQI PHARM TECH (SHIJIAZHUANG) CO LTD +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The dosage forms of cefadroxil currently in clinical use include tablets, capsules, and granules. These oral dosage forms need to be taken with water, and it will be difficult for patients who have difficulty swallowing or inconvenient water intake; although granules are specially designed for children. However, since most children cannot drink it by themselves, and it is inconvenient to take granules in schools or kindergartens, these dosage forms cannot fully meet the medication needs of all patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cefadroxil oral disintegrant tablet, and its prepn. method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Embodiment 1: Cefadroxil orally disintegrating tablet

[0047] components

weight

weight percentage

Cefadroxil

Mannitol

aspartame

132g (equivalent to cefadroxine

Ampicillin anhydrate 125g)

93g

1.5g

44% (equivalent to cefadroxil

Ampicillin anhydrate 41.7%)

31%

0.5%

[0048] Menthol

Sweet Orange Powder Flavor

5% Povidone 95% Ethanol

the solution

Low-substituted hydroxypropyl cellulose

microcrystalline cellulose

tartaric acid

sodium bicarbonate

Magnesium stearate

gross weight

1g

6g

Appropriate amount

12g

48g

1.5g

1.5g

3g

300g

0.33%

4.55%

Appropriate amount

4%

16%

0.5%

0.5%

1%

A total of 1000 pieces were made

[0049] Concrete preparation method is as follows:

[0050] Weigh cefadroxil, mannitol, aspartame, menthol, sweet orange powder essence and ...

Embodiment 2

[0051] Embodiment 2: Cefadroxil orally disintegrating tablet

[0052] components

weight

weight percentage

Cefadroxil

Erythrose

aspartame

Menthol

Sweet Orange Powder Flavor

50% ethanol

132g (equivalent to cefadroxine

Ampicillin anhydrate 125g)

180g

2.5g

1g

12g

Appropriate amount

26.4% (equivalent to cephalosporin

Amoxycillin anhydrous 25%)

60%

0.5%

0.2%

2.4%

Appropriate amount

[0053] Mannitol powder

Low-substituted hydroxypropyl cellulose

microcrystalline cellulose

citric acid

sodium bicarbonate

Magnesium stearate

gross weight

60g

20g

80g

5g

2.5g

5g

500g

12%

4%

16%

1%

0.5%

1%

A total of 1000 pieces were made

[0054] Concrete preparation method is as follows:

[0055] Weigh cefadroxil, erythrose, aspartame, menthol, sweet orange powder essence and part of low...

Embodiment 3

[0056] Embodiment 3: Cefadroxil orally disintegrating tablet

[0057] components

weight

weight percentage

Cefadroxil

Erythrose

aspartame

Menthol

Sweet Orange Powder Flavor

50% ethanol

Crospovidone

microcrystalline cellulose

citric acid

264g (equivalent to cefadroxine

Ampicillin anhydrate 250g)

184g

3g

2g

12g

Appropriate amount

40g

80g

6g

44% (equivalent to cefadroxil

Ampicillin anhydrate 41.7%)

30.7%

0.5%

0.33%

2%

Appropriate amount

6.7%

13.3%

1%

[0058] sodium bicarbonate

Magnesium stearate

gross weight

3g

6g

600g

0.5%

1%

A total of 1000 pieces were made

[0059] Concrete preparation method is as follows:

[0060] Weigh cefadroxil, erythrose, aspartame, menthol, sweet orange powder essence and part of cross-linked povidone that passed th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An oral disintegrating tablet of dracefal contains dracefal and the medicinal excipient (water-soluble filler, disintegrant, lubricant, wetting agent, or adhesive). Its preparing process is also disclosed. Its advantages are high disintegrating speed, quickly taking its effect, less residue and low by-effect.

Description

technical field [0001] The invention relates to a cefadroxil orally disintegrating tablet and a preparation method thereof. technical background [0002] Cefadroxil is a broad-spectrum antibiotic with high antibacterial activity against Staphylococcus aureus, various streptococci and anaerobic cocci. It also has a strong antibacterial effect on certain Enterobacteriaceae. Its bactericidal mechanism is similar to other β-lactam antibiotics, and it is achieved by inhibiting the formation of bacterial cell walls. The drug has the advantages of broad antibacterial spectrum, strong bactericidal effect, long half-life and the like. It is clinically used for respiratory tract, urinary tract, skin, and soft tissue infections caused by sensitive bacteria. Its adverse reactions are few and mild, mainly gastrointestinal reactions. [0003] The structural formula of cefadroxil is as follows: [0004] [0005] The dosage forms of cefadroxil currently in clinical use include table...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/545A61K9/20A61P31/04
Inventor 刘立云陈素锐陈玉洁闫随朝申东民张晓鹏
Owner CSPC ZHONGQI PHARM TECH (SHIJIAZHUANG) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products